Suppr超能文献

角膜胶原交联联合光治疗性角膜切削术和准分子激光原位角膜磨镶术治疗准分子激光原位角膜磨镶术后角膜扩张症

Corneal Collagen Crosslinking Combined with Phototherapeutic Keratectomy and Photorefractive Keratectomy for Corneal Ectasia after Laser in situ Keratomileusis.

作者信息

Zhu Wei, Han Yunfei, Cui Changxia, Xu Wenwen, Wang Xuan, Dou Xiaoxiao, Xu Linlin, Xu Yanyun, Mu Guoying

机构信息

Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

出版信息

Ophthalmic Res. 2018;59(3):135-141. doi: 10.1159/000480242. Epub 2018 Jan 17.

Abstract

PURPOSE

The aim of this study was to analyze the effects of corneal crosslinking (CXL) combined with phototherapeutic keratectomy (PTK) and photorefractive keratectomy (PRK) in halting the progression and improving the visual function of corneal ectasia after laser in situ keratomileusis (LASIK).

METHODS

PTK-PRK-CXL was performed on 14 eyes of 14 patients who developed corneal ectasia after LASIK. The visual acuity, spherical refraction and cylinder, corneal topography indices, thinnest corneal thickness (TCT), and endothelial cell count were evaluated at baseline and at 1, 3, 6, and 12 months postoperatively.

RESULTS

The mean uncorrected visual acuity improved significantly from 0.64 ± 0.36 logMAR preoperatively to 0.19 ± 0.12 logMAR at 12 months of follow-up (p < 0.001), while the mean best corrected visual acuity improved from 0.21 ± 0.14 logMAR at baseline to 0.04 ± 0.10 logMAR at 12 months postoperatively (p < 0.001). A significant decrease was observed in Kmax and Kmean values from 52.51 ± 6.74 and 43.55 ± 3.37 D at baseline to 45.72 ± 5.18 (p < 0.001) and 40.60 ± 3.05 D (p < 0.001) at the 1-year follow-up. The mean TCT decreased significantly from 419.07 ± 36.56 µm before treatment to 320.93 ± 39.78 µm at 12 months of follow-up (p < 0.001), and there was no significant endothelial cell loss (p > 0.05) beyond 6 months after treatment.

CONCLUSION

PTK-PRK-CXL is a promising procedure to halt the progression of post-LASIK keratectasia with significant visual quality improvement.

摘要

目的

本研究旨在分析角膜交联术(CXL)联合光治疗性角膜切削术(PTK)和准分子激光屈光性角膜切削术(PRK)对阻止准分子原位角膜磨镶术(LASIK)后角膜扩张进展及改善其视功能的效果。

方法

对14例LASIK术后发生角膜扩张的患者的14只眼进行PTK-PRK-CXL治疗。在基线时以及术后1、3、6和12个月评估视力、球镜度和柱镜度、角膜地形图指数、最薄角膜厚度(TCT)和内皮细胞计数。

结果

平均未矫正视力从术前的0.64±0.36 logMAR显著提高到随访12个月时的0.19±0.12 logMAR(p<0.001),而平均最佳矫正视力从基线时的0.21±0.14 logMAR提高到术后12个月时的0.04±0.10 logMAR(p<0.001)。观察到Kmax和Kmean值从基线时的52.51±6.74 D和43.55±3.37 D显著下降至1年随访时的45.72±5.18 D(p<0.001)和40.60±3.05 D(p<0.001)。平均TCT从治疗前的419.07±36.56 µm显著下降至随访12个月时的320.93±39.78 µm(p<0.001),且治疗后6个月后内皮细胞无显著丢失(p>0.05)。

结论

PTK-PRK-CXL是一种有前景的手术方法,可阻止LASIK术后角膜扩张的进展,并显著改善视觉质量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验